FindTrial
Sign In

To compare the early treatment response in patients with locally advanced lung cancer (stage IIIb and IIIa) planned with 3DCRT vs. 4DCT based radiotherapy planning

EVALUATION OF FOUR DIMENSIONAL COMPUTED TOMOGRAPHY(4DCT) BASED INTENSITY MODULATED RADIOTHERAPY/VOLUMETRIC MODULATED ARC THERAPY (IMRT/VMAT) AND 3DCRT PLANNING FOR LOCALLY ADVANCED LUNG CANCER- DOSIMETRIC EVALUATION AND EARLY CLINICAL OUTCOME

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/028024
Enrollment
15
Registered
2020-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- LUNG CANCER Health Condition 2: C348- Malignant neoplasm of overlappingsites of bronchus and lung

Interventions

None listed

Sponsors

ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PFT-FEV1 >40% OF PREDICTED HEMOGLOBIN- BIOPSY PROVEN NON SMALL CELL CANCER INFORMED CONSENT

Exclusion criteria

Exclusion criteria: PREVIOUS ONCOLOGIC THERAPY WITH SURGERY AND RADIOTHERAPY DISTANT METASTATSIS UNCONTROLLED COMORBID CONDITIONS -HYPERTENSION,DIABETES MELLITUS

Design outcomes

Primary

MeasureTime frame
To compare and evaluate plan quality in terms of Target coverage and OARs sparing (Dosimetric distribution) of four dimensional computed tomography(4DCT) based IMRT/VMAT plan versus 3 Dimensional Conformal Radiotherapy(3DCRT) Planning in stage III non small cell lung cancer patients Timepoint: 3 MONTHS—

Secondary

MeasureTime frame
To evaluate the early clinical outcome of Stage III Non small cell lung cancer patients treated with 4DCT based IMRT/VMATTimepoint: 6 MONTHS—

Countries

India

Contacts

Public ContactNIDHUN V ASHOK

AIIMS

rambha151@gmail.com9310012026

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026